-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Transcription Factors and Epigenetics

PhD Trainee
Program: Scientific Workshops @ ASH
Wednesday, December 2, 2020: 8:35 AM-9:15 AM
Moderator:
Disclosures:
Steidl: Aileron Therapeutics: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Pieris Pharmaceuticals: Consultancy; Bayer Healthcare: Research Funding; Stelexis Therapeutics: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; VorBiopharma: Consultancy; Novartis: Membership on an entity's Board of Directors or advisory committees.
Leukemia-Associated DNMT3A Mutations Drive Functional and Epigenetic Heterogeneity of Hematopoiesis

Olga A Guryanova, MD, PhD

University of Florida College of Medicine, Gainesville, FL
Live Q&A

Olga A Guryanova, MD, PhD

University of Florida College of Medicine, Gainesville, FL
Gene Expression Control By the CCR4-NOT (CNOT) RNA Deadenylation Complex in Acute Myeloid Leukemia

Ly Vu, PhD

Simon Fraser University, Burnaby, BC, Canada; BC cancer agency, vancouver, BC, Canada
Live Q&A

Ly Vu, PhD

Simon Fraser University, Burnaby, BC, Canada
Beta-Catenin-TCF/LEF-Mediated Transcription Fine Tunes Granulopoiesis in Steady-State and Emergency Granulopoiesis

Meritxell Alberich-Jorda

Department of Hemato-oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic; Department of Pediatric Hematology and Oncology, Charles University, 2nd Faculty of Medicine, Prague, Czech Republic
Live Q&A

Meritxell Alberich-Jorda

Department of Hemato-oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
Therapeutic Targeting of STAT3 in MDS and AML Stem Cells

Aditi Shastri, MD

Department of Hematology and Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Astoria, NY
Live Q&A

Aditi Shastri, MD

Department of Hematology and Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Astoria, NY
See more of: Scientific Workshops @ ASH
<< Previous Session | Next Session >>